CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 7 filers reported holding CRISPR THERAPEUTICS AG in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $300,936 | -19.1% | 6,630 | 0.0% | 0.06% | -4.4% |
| Q2 2023 | $372,209 | +24.1% | 6,630 | 0.0% | 0.07% | 0.0% |
| Q1 2023 | $299,875 | +11.3% | 6,630 | 0.0% | 0.07% | -27.7% |
| Q4 2022 | $269,510 | -37.8% | 6,630 | 0.0% | 0.09% | +3.3% |
| Q3 2022 | $433,000 | +7.4% | 6,630 | 0.0% | 0.09% | -5.2% |
| Q2 2022 | $403,000 | -3.1% | 6,630 | 0.0% | 0.10% | +39.1% |
| Q1 2022 | $416,000 | -92.3% | 6,630 | -80.1% | 0.07% | -90.5% |
| Q2 2021 | $5,403,000 | +63.2% | 33,376 | +22.9% | 0.73% | +53.7% |
| Q1 2021 | $3,310,000 | – | 27,163 | – | 0.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $32,581,000 | 55.55% |
| NEA Management Company, LLC | 1,590,002 | $103,907,000 | 5.19% |
| ARK Investment Management | 8,237,122 | $538,296,000 | 3.75% |
| Nikko Asset Management Americas, Inc. | 4,262,736 | $277,078,000 | 3.54% |
| CLOUGH CAPITAL PARTNERS L P | 414,767 | $27,105,000 | 2.89% |
| Integral Health Asset Management, LLC | 220,000 | $14,377,000 | 2.79% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,268,000 | 2.48% |
| HC Advisors, LLC | 53,944 | $3,525,000 | 2.43% |
| Green Alpha Advisors, LLC | 27,466 | $1,795,000 | 1.52% |
| EFG Asset Management (North America) Corp. | 84,356 | $5,516,000 | 1.28% |